432SN, Senior Manager, Clinical Site Budgets

Job Code 432SN

Description

Fate Therapeutics is seeking a Senior Manager, Clinical Site Budgets responsible for the development of study-specific site budget templates and for the direct negotiation of site budgets with investigative sites. The Senior Manager, Clinical Site Budgets will also be responsible for partnering internally to support budget analysis and management activities. This is a full-time position located remotely in the San Francisco Bay Area or at our corporate headquarters in San Diego, CA reporting to the Director, Clinical Outsourcing.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 432SN.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

431SN, Associate Director / Senior Manager, Clinical Site Budgets & Clinical Outsourcing

Job Code 431SN

Description

Fate Therapeutics is seeking an Associate Director / Senior Manager, Clinical Site Budgets & Clinical Outsourcing responsible for the development of study-specific site budget templates and for the direct negotiation of site budgets with investigative sites. The successful candidate will lead key vendor sourcing activities from Requests for Information/Proposals (RFI/RFP) to vendor selection This is a full-time position located remotely in the San Francisco Bay Area or at our corporate headquarters in San Diego, CA reporting to the Director, Clinical Outsourcing.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 431SN.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

402MD, Associate Clinical Trial Manager

Job Code 402MD

Description

Fate’s Clinical Operations team is currently seeking a talented and motivated clinical operations professional to support our Hematology/Oncology clinical trials. The successful candidate must have experience managing trials and a good knowledge of clinical operations, GCP and FDA regulatory environment. Oncology trial experience required. This is a full-time position reporting to the Associate Director, Clinical Operations, and is located at our Company’s headquarters in San Diego, California or remotely from the San Francisco, California area.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 402MD.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

348SW, Clinical Trial Manager

Job Code 348SW

Description

Fate’s Clinical Operations team is currently seeking a talented and motivated clinical operations professional to support our clinical trials. The successful candidate must have experience managing Phase I-III trials and a good knowledge of clinical operations, GCP and FDA regulatory environment. Oncology trial experience preferred. This is a full-time position reporting to the Director / Associate Director, Clinical Operations, and is located at our Company’s headquarters in San Diego, California or in South San Francisco, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 348SW.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.